Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight

Page 1 of 2

Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark. On one hand, there will likely be strong resistance given the past failures of several rallies at that level, and the recent commentary by Goldman Sachs which claimed that oil’s rally would run into a wall of resistance at $55. On the other hand, WTI has rallied strongly in recent days and sentiment around the commodity is somewhat bullish.

In this article, we’ll take a closer look at five stocks that are commanding the spotlight today, which are Yum! Brands, Inc. (NYSE:YUM), Booz Allen Hamilton Holding Corporation (NYSE:BAH), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), The Medicines Company (NASDAQ:MDCO), and Resources Connection, Inc. (NASDAQ:RECN). We’ll also delve into the latest 13F data to uncover how the smart money traded each stock during the second quarter.

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).

kfc, australia, hill, australian, take, fried, retail, unhealthy, red, fatty, business, chicken, restaurant, suburban, drivethrough, suburb, kentucky, junk, away, sanders, box,

Nils Versemann /

Yum! Brands, Inc. (NYSE:YUM) shares are 2% lower in extended market trading after the company reported earnings of $1.09 per share on revenue of $3.32 billion for its third quarter. Yum’s bottom-line results were in-line with the Street’s estimates, while the company’s top-line missed by $200 million. According to the company, same-store sales inched up 4% year-over-year for its KFC division, including U.S. same-store sales growing by 6%. China core operating profit jumped by 14%, and the company is on track to finalize the separation of its operations in China on November 1, 2016. Year-to-date through October 4, the company has repurchased 54.5 million shares at an average price of $82. Yum expects to repurchase an additional $0.9 billion worth of its shares before the end of 2016. Stephen Mandel‘s Lone Pine Capital raised its stake in Yum! Brands, Inc. (NYSE:YUM) by 560% during the second quarter to just under 10 million shares at the end of June.

Follow Yum Brands Inc (NYSE:YUM)
Trade (NYSE:YUM) Now!

Booz Allen Hamilton Holding Corporation (NYSE:BAH) is in the spotlight after the company’s stock fell by 3.7% on Wednesday on the news that one of its employees had been arrested by the FBI. The employee, who has since been fired, has been charged with the theft of government property, particularly in relation to classified information used by the NSA. Booz Allen is cooperating fully with the government to help it get to the bottom of the case. Of the 749 hedge funds that we track which filed 13Fs for the June quarter, 27 of them were long Booz Allen Hamilton Holding Corporation (NYSE:BAH) at the end of the second quarter, up by nine funds from the end of the first quarter.

Follow Booz Allen Hamilton Holding Corp (NYSE:BAH)
Trade (NYSE:BAH) Now!

On the next page, we’ll find out why Alnylam Pharmaceuticals, The Medicines Company, and Resources Connection are taking it on the chin in extended trading.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!